Replies to post #116153 on Biotech Values

[oldberkeley]

there's no way in hell I'd play HGSI in front of the FDA's decision on Benlysta.

After your reply to my HGSI question a few weeks ago, and doing some further DD, I decided exactly the same thing.

Poor risk/reward.

[BTH]

Do you really want to risk what would in all likelihood be substantial downside if any hiccup with the FDA for a measly $2 increase?

I agree.

I wouldn't go anywhere near it. Owned it sub-$2.00 and sold slightly above $10 (wish I held longer, for sure).

Right now, if FDA declines Benlysta, stock drops in an epic direction of ugliness (I would say 50%).

Do I think that will happen? Not likely, but the FDA doesn't really have a rhyme or reason as to what they seem to do these days.